Article Text

Findings that shed new light on the possible pathogenesis of a disease or an adverse effect
Inflammatory sciatica due to spinal tophaceous gout
  1. Dominique Buenzli1,
  2. Alexander So2
  1. 1
    Centre Hospitalier Universitaire Vaudois, Medicine, Rue de Bugnon, Lausanne, 1011, Switzerland
  2. 2
    University of Lausanne, Musculoskeletal Medicine, Avenue Pierre Decker, Lausanne, 1011, Switzerland


A 73-year-old woman with chronic tophaceous gout presented with acute right-sided sciatica. Conventional radiology and CT scan of the lumbar spine revealed severe degenerative changes at the level of L3/4 and L4/5 disc and tophaceous deposits around the facet joints bilaterally. Investigations revealed a raised acute phase response (C reactive protein 97 mg/l, erythrocyte sedimentation rate >100 mm/h), leucocytosis and thrombocytosis. Because of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity and intolerance to colchicine, a local steroid infiltration of the L4–5 facet joint was administered with a partial response. The patient was treated with anakinra 100 mg daily administered for 3 days. The treatment led to rapid clinical improvement of sciatica as well as normalisation of the acute phase response. She was subsequently maintained on anakinra 100 mg three times weekly with total resolution of sciatic pain.

Statistics from


  • Competing interests: none.

  • Patient consent: Patient/guardian consent was obtained for publication.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.